Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2014.
Total revenue for the third quarter of 2014 was $29.6 million, an increase of 62% from $18.3 million in the third quarter of 2013. Organic revenue (excluding revenue attributable to the DVS Sciences acquisition, comprised of the CyTOF® 2 system and proteomics analytical consumables) was $24.7 million, an increase of 35% over the same quarter in 2013.
Help employers find you! Check out all the jobs and post your resume.
